• News
    • Opinion Editorial
    • Videos
    • Podcasts
  • Community
    • Members
  • Discussions
  • Patient Centers
    • View All
    • Why Join?
  • Write for us
    Sign in Sign up


    • News
      • Opinion Editorial
      • Videos
      • Podcasts
    • Community
      • Members
    • Discussions
    • Patient Centers
      • View All
      • Why Join?
    • Write for us
    Sign in Sign up

    Tag: Zimbabwe

    Beyond The Roundup | Zimbabwe Green Lights Importation of Ivermectin to Treat COVID-19

    While in the US. the NIH’s current stance on Ivermectin is a neutral one tone. neither for, nor against the use of the drug for…

    TrialSite Staff
    TrialSite Staff February 20, 2021
    0 Comments
    Zimbabwe Officials Green Light Massive Importation of Ivermectin to Treat COVID-19

    Zimbabwe Officials Green Light Massive Importation of Ivermectin to Treat COVID-19

    Recently, TrialSite reported on an abrupt shift in point of view among health officials and regulators concerning the use of Ivermectin targeting SARS-CoV-2, the virus behind…

    TrialSite Staff
    TrialSite Staff February 16, 2021
    1 Comment
    COVID-19 Gets Serious in Zimbabwe while National Physicians Group Calls Ivermectin ‘Game Changer’

    COVID-19 Gets Serious in Zimbabwe while National Physicians Group Calls Ivermectin ‘Game Changer’

    The College of Primary Care Physicians of Zimbabwe (CPCPZ) has formally appealed to the government for the southeastern African nation of Zimbabwe to accept Ivermectin as…

    TrialSite Staff
    TrialSite Staff January 28, 2021
    0 Comments
    HIV Vaccie

    University of Zimbabwe College of Health & Clinical Trials Research Drives Successful Enrollment in HVTN705 HIV Vaccine Study

    500 participants from Zimbabwe have led participation to represent the first country in the Sub-Saharan region to complete the successful enrollment of participants who are…

    TrialSite Staff
    TrialSite Staff July 8, 2019
    0 Comments

    Read more about…

    Alzheimer Alzheimer's Disease Artificial Intelligence Autoimmune Disease Breast Cancer Cancer Cardiovascular Challenging Results China Clinical Research Clinical Research as a Care Option Clinical Trials CNS Coronavirus covid-19 COVID-19 Dementia Diabetes Digital Health Digital Media FDA Gene Therapy Immunotherapy India Investigator Content Investigator Profiles Investor Watch Ivermectin Leading Pharma Leading Sites Neurology NIH Oncology Patient Recruitment Pharma Watch Positive Results Price Watch Prostate Cancer Research SARS-CoV-2 Site Challenges Site Success Site Watch UK Vaccine

    About Us

    TRIALSITE NEWS IS  DEDICATED TO TRANSPARENT AND OPEN COVERAGE OF CLINICAL RESEARCH TRIAL SITES AROUND THE GLOBE. BASED IN THE SILICON SLOPES IN DOWNTOWN SALT LAKE CITY, UTAH, WE ARE FOUNDED BY A TEAM OF EXPERTS IN THE CLINICAL TRIALS INDUSTRY AND DEDICATED TO TRANSPARENCY, QUALITY AND CLINICAL TRIAL INNOVATION.

    © 2021 - Trial Site News
    • Terms of Service
    • Privacy Policy

    TrialSite News
    159 W Broadway, Suite 200
    Salt Lake City, UT 84101

    Report Content

    Harassment or bullying behavior
    Contains mature or sensitive content
    Contains misleading or false information
    Contains abusive or derogatory content
    Anything overly promotional selling products or services

    Block Member?

    Please confirm you want to block this member.

    You will no longer be able to:

    • See blocked member's posts
    • Mention this member in posts
    • Invite this member to groups
    • Message this member
    • Add this member as a connection

    Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.